Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This pilot trial studies how well sonidegib and buparlisib work in treating patients with
basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib
may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase:
Phase 2
Details
Lead Sponsor:
Anne Chang
Collaborators:
National Cancer Institute (NCI) Novartis Pharmaceuticals